Proteome Sciences (LON:PRM) Shares Down 8.1% – Time to Sell?

Proteome Sciences plc (LON:PRM) shares dropped 8.1% during mid-day trading on Wednesday . The stock traded as low as GBX 1.70 and last traded at GBX 1.92. Approximately 181,265 shares were traded during trading, a decline of 70% from the average daily volume of 598,638 shares. The stock had previously closed at GBX 2.09.

Proteome Sciences Stock Performance

The company has a debt-to-equity ratio of -258.66, a quick ratio of 0.37 and a current ratio of 0.20. The company has a market cap of £5.96 million, a price-to-earnings ratio of -1.50 and a beta of 0.07. The firm’s 50-day moving average price is GBX 2.39 and its 200 day moving average price is GBX 2.36.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.